Evidence map›Paper›PMID 36751176›Full record

ArticleCureus2023

Long-Term Outcomes of COVID-19 Otolaryngology Symptoms in Saudi Arabia.

Musaed Alzahrani, Almaha H Alshathri, Khalil Alduraibi, Aljohara H Alshathri, Tahani F Alanazi, Hamza Alandijani, Jumana A Almajed, Khloud A Wajdi

Abstract read
In one paragraph

Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Musaed AlzahraniDepartment of Otolaryngology - Head and Neck Surgery, King Fahad Specialist Hospital, Dammam, SAU.
Almaha H AlshathriCollege of Medicine, King Saud University, Riyadh, SAU.
Khalil AlduraibiDepartment of General Medicine, College of Medicine and Surgery, King Saud University, Riyadh, SAU.
Aljohara H AlshathriCollege of Medicine, King Saud University, Riyadh, SAU.
Tahani F AlanaziDepartment of Otolaryngology - Head and Neck Surgery, University of Tabuk, Tabuk, SAU.
Hamza AlandijaniCollege of Medicine, Taibah University, Almadinah Almunawwarah, SAU.
Jumana A AlmajedDepartment of Otolaryngology - Head and Neck Surgery, King Abdulaziz University, Jeddah, SAU.
Khloud A WajdiDepartment of Pharmacology, Ibn Sina National College, Jeddah, SAU.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe objectives of the study are to measure the prevalence of the most common symptoms and different long-term otorhinolaryngology manifestations among COVID-19-positive patients in Saudi Arabia.

methodsThis is a cross-sectional study. Data were collected using a Google form questionnaire sent to the study sample. The data were entered and then analyzed using SPSS version 25.0 (IBM Corp, Armonk, NY).

resultsA total of 13,530 COVID-19-positive adult patients were enrolled in the current study. The most reported initial symptom was fever (53.3%) followed by headache (49.3%), sore throat (48.9%), nasal congestion, rhinorrhea (42.1%), and loss of smell and/or loss of taste (37.8%). Regarding the continuation of the symptoms, vertigo was mentioned by 5852 (43.3%) followed by fever (16.1%) and blocked ear sensation (15.6%).

conclusionThe most commonly reported initial symptom was fever followed by headache. Interestingly, vertigo is a frequent long-term complication after a COVID-19 infection. Other otology-related symptoms include hearing loss and ear blockage, while rhinology and upper airway-related symptoms were less frequent in the long term after the acute phase of the infection.

Indexed as

covid- 19long-term complicationsorlotologyvertigo

Identifiers

PMID36751176
PMCPMC9899518

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.